Cue Biopharma Inc. (CUE)
NASDAQ: CUE
· Real-Time Price · USD
0.81
0.02 (2.53%)
At close: Aug 15, 2025, 3:59 PM
0.83
2.48%
After-hours: Aug 15, 2025, 06:54 PM EDT
Cue Biopharma Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 27.49M | 13.14M | 22.46M | 32.42M | 30.03M | 41.03M | 48.51M | 54.69M | 52.9M | 56.32M | 51.61M | 29.73M | 66.13M | 67.93M | 64.37M | 67.63M | 73.92M | 73.26M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 4.99M | 9.88M | 24.67M | 29.46M | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | 153K | 152K | 152K | 151K | 151K | 151K | 150K | 150K | n/a | 150K | 150K | 150K | 150K | 150K | 150K | 150K | 150K |
Other Long-Term Assets | 4.29M | 2.06M | 2.06M | 2.8M | 2.8M | 2.8M | 2.81M | 3.1M | 3.1M | 3.1M | 3.24M | 3.25M | 3.93M | 2.81M | 2.86M | 2.76M | 2.77M | 2.72M |
Receivables | 532K | n/a | 945K | 3.15M | 1.85M | 1.4M | 1.7M | 1.66M | 1.14M | 196K | 57.25K | 796K | 736K | 6.05M | 3.14M | 771K | 1.9M | 1.41M |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 2.82M | 1.88M | 805K | 1.68M | 2.02M | 2.24M | 1.24M | 1.17M | 1.91M | 2.36M | 841.22K | 1.72M | n/a | n/a | 954.79K | 1.85M | 3.85M | 2.73M |
Total Current Assets | 30.84M | 15.93M | 25.14M | 37.26M | 33.9M | 44.67M | 51.45M | 57.52M | 60.94M | 68.75M | 77.19M | 61.7M | 69M | 75.95M | 68.47M | 70.25M | 79.68M | 77.41M |
Property-Plant & Equipment | 5.57M | 4.11M | 4.84M | 4.6M | 5.48M | 6.33M | 7.12M | 8.13M | 8.98M | 9.82M | 10.7M | 11.2M | 11.66M | 11.8M | 11.92M | 5.71M | 7.08M | 8.44M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 9.86M | 6.32M | 7.05M | 7.55M | 8.43M | 9.28M | 10.08M | 11.37M | 12.23M | 12.93M | 14.1M | 14.6M | 15.74M | 14.76M | 14.93M | 8.62M | 9.99M | 11.32M |
Total Assets | 40.71M | 22.25M | 32.19M | 44.81M | 42.33M | 53.95M | 61.53M | 68.89M | 73.16M | 81.68M | 91.28M | 76.3M | 84.75M | 90.7M | 83.4M | 78.88M | 89.67M | 88.72M |
Account Payables | 3.63M | 3.78M | 2.82M | 6.47M | 3.91M | 3.92M | 3.5M | 2.48M | 2.36M | 2.15M | 2.73M | 2.04M | 1.57M | 2.62M | 2.59M | 2.47M | 2.99M | 2.52M |
Deferred Revenue | n/a | n/a | 85K | n/a | 976K | 1.79M | 2.11M | 2.24M | 2.55M | 2.52M | n/a | n/a | n/a | n/a | 645.35K | 5.26M | 6.8M | 7.14M |
Short-Term Debt | 4.53M | 3.37M | 4.33M | 6.86M | 3.96M | 3.96M | 3.96M | 3.96M | 7.33M | 6.29M | 1.96M | 4.3M | 3.2M | 5.39M | 1.97M | 3.63M | 4.87M | 4.99M |
Other Current Liabilities | 14.72M | 2.61M | 1.81M | -237K | 3.13M | 3.11M | 1.92M | n/a | -6.73M | -6.66M | 535.00 | -3.33M | -3.2M | -5.39M | 2.61M | -7.27M | -9.75M | -9.98M |
Total Current Liabilities | 19.25M | 15.5M | 13.69M | 16.79M | 16.46M | 18.09M | 17.08M | 17.21M | 16.31M | 13.81M | 11.55M | 10.22M | 8.32M | 11.41M | 12.79M | 15.36M | 16.67M | 16.63M |
Long-Term Debt | 3.1M | n/a | 1M | 1.33M | 2.29M | 3.24M | 4.2M | 5.16M | 6.12M | 7.08M | 8.04M | 8.99M | 9.91M | 9.86M | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 190K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -658 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | 3.29M | 176K | 1M | 2.65M | 4.25M | 5.82M | 7.36M | 9.02M | 10.85M | 12.86M | 14.05M | 15.31M | 16.67M | 14.62M | 5.12M | n/a | 89K | 2.42M |
Total Liabilities | 22.55M | 15.67M | 14.69M | 19.44M | 20.71M | 23.91M | 24.45M | 26.22M | 27.16M | 26.66M | 25.6M | 25.54M | 24.99M | 26.03M | 17.91M | 15.36M | 16.76M | 19.05M |
Total Debt | 7.63M | 7.13M | 8.88M | 9.51M | 11.26M | 13M | 14.7M | 16.38M | 18.04M | 18.7M | 19.32M | 19.61M | 19.87M | 20.01M | 10.05M | 3.63M | 4.87M | 6.07M |
Common Stock | 76K | 62K | 62K | 60K | 48K | 48K | 47K | 45K | 44K | 43K | 43.04K | 35K | 35K | 34K | 32.2K | 32K | 31K | 31K |
Retained Earnings | -362.6M | -354.12M | -341.86M | -332.37M | -323.71M | -313.54M | -301.19M | -287.75M | -276.75M | -263.56M | -250.46M | -235.86M | -224.91M | -211.7M | -197.45M | -189.06M | -176.07M | -165.79M |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -5K | -39K | -95.87K | -92K | n/a | 0.00 | -0.00 | n/a | -0.00 | -0.00 |
Shareholders Equity | 18.16M | 6.58M | 17.5M | 25.37M | 21.62M | 30.04M | 37.09M | 42.67M | 46M | 55.02M | 65.68M | 50.76M | 59.76M | 64.67M | 65.49M | 63.52M | 72.91M | 69.67M |
Total Investments | n/a | 153K | 152K | 152K | 151K | 151K | 151K | 150K | 4.99M | 9.88M | 24.67M | 29.46M | 150K | 150K | 150K | 150K | 150K | 150K |